• Assure Holdings (IOM) has applied to list on the NASDAQ Capital Market and implement changes to its business to meet the exchange’s requirements
  • These changes include a reverse stock split, the adoption of new committee charters and the adoption of a new code of ethics
  • The company believes the listing will be a catalyst for its growth plans
  • Assure Holdings provides a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries
  • Assure Holdings (IOM) is unchanged trading at $2.00 per share

Assure Holdings (IOM) has applied to list on the NASDAQ Capital Market and implement changes to its business to meet the exchange’s requirements.

These changes include the following:

  • A 5:1 share consolidation of its common stock, effective at 5:30 pm ET on September 7, 2021. After the reverse split, Assure will have approximately 11,836,288 shares issued and outstanding
  • The realignment of its Board committees
  • The adoption of new charters for its Audit Committee, Compensation Committee and Nomination and Corporate Governance Committee
  • The adoption of a new code of business conduct and ethics
  • Amendments to bylaws concerning court forum provisions, quorum requirements for shareholder meetings, and the Board’s right to change its number of directors

John A. Farlinger, Assure’s Executive Chairman and CEO, stated,

“We believe that listing our common stock on the NASDAQ is a major step forward for Assure. We made a strategic decision that now was the time to pursue a listing of our common stock on a national exchange in the United States. We believe the company is currently prepared to take advantage of the accelerated benefits a NASDAQ listing provides, including increasing Assure’s visibility and awareness, providing additional liquidity to our investors, improving access to capital and enhancing the value of our common stock for future M&A transactions.”

Assure Holdings provides a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.

Assure Holdings (IOM) is unchanged trading at $2.00 per share as of 9:38 am ET.

More From The Market Online

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.

Cloud DX signs fourth contract with a provincial health authority

Cloud DX (TSXV:CDX) signs its fourth contract with a provincial health authority for remote patient monitoring.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.